Approvals/TGA/EYLEA aflibercept 114.3 mg/mL solution for intravitreal injection vial with needle

Approved

STANDARD

EYLEA aflibercept 114.3 mg/mL solution for intravitreal injection vial with needle

Bayer Australia Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: e5fbfa74fa2002cb
Product Name: EYLEA aflibercept 114.3 mg/mL solution for intravitreal injection vial with needle
Artg Id: 405862
Artg Name: EYLEA aflibercept 114.3 mg/mL solution for intravitreal injection vial with needle
Sponsor: Bayer Australia Ltd
Company Detail Path: /organization/bayer-australia-ltd
Artg Date: 2024-06-14
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2012-CMI-02075-3
Product Information: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2024-PI-02041-1

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

e5fbfa74fa2002cb

Type

Standard